Cargando…

Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats

Conventional influenza vaccines need to be designed and manufactured yearly. However, they occasionally provide poor protection owing to antigenic mismatch. Hence, there is an urgent need to develop universal vaccines against influenza virus. Using nucleoprotein (NP) and extracellular domain of matr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenling, Huang, Baoying, Wang, Xiuping, Tan, Wenjie, Ruan, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814692/ https://www.ncbi.nlm.nih.gov/pubmed/31240620 http://dx.doi.org/10.1007/s12250-019-00138-9

Ejemplares similares

Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli
por: Wang, Wenling, et al.
Publicado: (2012)

Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice
por: Huang, Baoying, et al.
Publicado: (2012)

Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
por: Mittal, Nidhi, et al.
Publicado: (2021)

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle
por: Kim, Ki-Hye, et al.
Publicado: (2022)

Optimisation of Prime–Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine
por: Chen, Hong, et al.
Publicado: (2012)

Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins
por: Lee, Yu-Na, et al.
Publicado: (2015)

A recombinant DNA and vaccinia virus prime–boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice
por: Deng, Yao, et al.
Publicado: (2009)

Potentiation of Recombinant NP and M1-Induced Cellular Immune Responses and Protection by Physical Radiofrequency Adjuvant
por: Li, Yibo, et al.
Publicado: (2021)

Expression of Influenza M2e-NP Recombinant Fusion Protein in Escherichia coli BL21 (DE3) and Its Binding to Antibodies
por: Tan, Mei Peng, et al.
Publicado: (2022)

Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
por: Kim, Jinuk, et al.
Publicado: (2020)

VLPs containing stalk domain and ectodomain of matrix protein 2 of influenza induce protection in mice
por: Shi, Lili, et al.
Publicado: (2023)

The effects of transcription and recombination on mutational dynamics of short tandem repeats
por: Zavodna, Monika, et al.
Publicado: (2018)

Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses
por: Holechek, Susan A., et al.
Publicado: (2013)

Virus-Like Particles Containing the Tetrameric Ectodomain of Influenza Matrix Protein 2 and Flagellin Induce Heterosubtypic Protection in Mice
por: Wang, Li, et al.
Publicado: (2013)

A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
por: An, Yaling, et al.
Publicado: (2022)

Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
por: Olukitibi, Titus Abiola, et al.
Publicado: (2022)

Author Correction: Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
por: Kim, Jinuk, et al.
Publicado: (2022)

The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
por: Saelens, Xavier
Publicado: (2019)

An antigenic epitope of influenza virus nucleoprotein (NP) associated with polymeric forms of NP
por: Prokudina, Elena N, et al.
Publicado: (2008)

Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and Yield
por: Wrapp, Daniel, et al.
Publicado: (2023)

Live-Cell Imaging of Vaccinia Virus Recombination
por: Paszkowski, Patrick, et al.
Publicado: (2016)

Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization
por: Noy-Porat, Tal, et al.
Publicado: (2023)

Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice
por: Yin, Yuan, et al.
Publicado: (2020)

Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus
por: Lan, Jiaming, et al.
Publicado: (2018)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
por: McMahon, Meagan, et al.
Publicado: (2019)

Tandem repeat disorders
por: Ryan, Calen P
Publicado: (2019)

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
por: Deng, Yao, et al.
Publicado: (2018)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020)

Protection against infectious bronchitis virus by spike ectodomain subunit vaccine
por: Eldemery, Fatma, et al.
Publicado: (2017)

The μ Switch Region Tandem Repeats Are Important, but Not Required, for Antibody Class Switch Recombination
por: Luby, Thomas M., et al.
Publicado: (2001)

Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19
por: Xu, Kun, et al.
Publicado: (2021)

Crystal structure of the leucine-rich repeat ectodomain of the plant immune receptor kinase SOBIR1
por: Hohmann, Ulrich, et al.
Publicado: (2019)

Vaccinia Virus Recombinants: Expression Vectors and Potential Vaccines
por: MACKETT, M.
Publicado: (1994)

A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats
por: Mezhenskaya, Daria, et al.
Publicado: (2021)

Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses
por: Wang, Huijuan, et al.
Publicado: (2019)

Identification of a Novel Splice Variant Form of the Influenza A Virus M2 Ion Channel with an Antigenically Distinct Ectodomain
por: Wise, Helen M., et al.
Publicado: (2012)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019)

MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection
por: Gao, Feixia, et al.
Publicado: (2020)

Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination
por: Ren, Yanqin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4b0l69laed2mtuoa5v8hko1q77